Annual CAPEX
$13.62 M
+$7.99 M+141.85%
31 December 2023
Summary:
Castle Biosciences annual capital expenditures is currently $13.62 million, with the most recent change of +$7.99 million (+141.85%) on 31 December 2023. During the last 3 years, it has risen by +$8.87 million (+186.70%). CSTL annual CAPEX is now at all-time high.CSTL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$6.38 M
+$1.15 M+21.97%
30 September 2024
Summary:
Castle Biosciences quarterly capital expenditures is currently $6.38 million, with the most recent change of +$1.15 million (+21.97%) on 30 September 2024. Over the past year, it has increased by +$3.92 million (+159.80%). CSTL quarterly CAPEX is now -30.31% below its all-time high of $9.15 million, reached on 31 March 2024.CSTL Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$24.55 M
+$3.92 M+19.02%
30 September 2024
Summary:
Castle Biosciences TTM capital expenditures is currently $24.55 million, with the most recent change of +$3.92 million (+19.02%) on 30 September 2024. Over the past year, it has increased by +$12.94 million (+111.38%). CSTL TTM CAPEX is now at all-time high.CSTL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +141.8% | +159.8% | +111.4% |
| 3 y3 years | +186.7% | +588.0% | +672.3% |
| 5 y5 years | +4817.3% | +3742.2% | +4023.6% |
CSTL CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +291.1% | -30.3% | +1486.6% | at high | +683.2% |
| 5 y | 5 years | at high | +4817.3% | -30.3% | +3742.2% | at high | +4023.6% |
| alltime | all time | at high | +4817.3% | -30.3% | >+9999.0% | at high | >+9999.0% |
Castle Biosciences CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.38 M(+22.0%) | $24.55 M(+19.0%) |
| June 2024 | - | $5.23 M(-42.9%) | $20.63 M(+6.1%) |
| Mar 2024 | - | $9.15 M(+141.3%) | $19.43 M(+42.7%) |
| Dec 2023 | $13.62 M(+141.9%) | $3.79 M(+54.5%) | $13.62 M(+17.3%) |
| Sept 2023 | - | $2.46 M(-39.2%) | $11.62 M(+3.7%) |
| June 2023 | - | $4.04 M(+20.9%) | $11.20 M(+30.7%) |
| Mar 2023 | - | $3.34 M(+86.8%) | $8.57 M(+52.1%) |
| Dec 2022 | $5.63 M(+61.7%) | $1.79 M(-12.3%) | $5.63 M(+18.9%) |
| Sept 2022 | - | $2.04 M(+45.1%) | $4.74 M(+30.6%) |
| June 2022 | - | $1.41 M(+249.5%) | $3.63 M(+15.7%) |
| Mar 2022 | - | $402.00 K(-55.0%) | $3.13 M(-10.0%) |
| Dec 2021 | $3.48 M | $893.00 K(-3.7%) | $3.48 M(+9.6%) |
| Sept 2021 | - | $927.00 K(+1.5%) | $3.18 M(-23.5%) |
| June 2021 | - | $913.00 K(+21.7%) | $4.16 M(-16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $750.00 K(+27.3%) | $5.00 M(+5.3%) |
| Dec 2020 | $4.75 M(+407.0%) | $589.00 K(-69.1%) | $4.75 M(+5.4%) |
| Sept 2020 | - | $1.91 M(+8.5%) | $4.51 M(+62.8%) |
| June 2020 | - | $1.76 M(+251.2%) | $2.77 M(+132.1%) |
| Mar 2020 | - | $500.00 K(+44.1%) | $1.19 M(+27.3%) |
| Dec 2019 | $937.00 K(+238.3%) | $347.00 K(+109.0%) | $937.00 K(+57.4%) |
| Sept 2019 | - | $166.00 K(-7.8%) | $595.40 K(+15.3%) |
| June 2019 | - | $180.00 K(-26.2%) | $516.40 K(+4.9%) |
| Mar 2019 | - | $244.00 K(+4418.5%) | $492.40 K(+77.8%) |
| Dec 2018 | $277.00 K(-44.0%) | $5400.00(-93.8%) | $277.00 K(+2.0%) |
| Sept 2018 | - | $87.00 K(-44.2%) | $271.60 K(+47.1%) |
| June 2018 | - | $156.00 K(+445.5%) | $184.60 K(+545.5%) |
| Mar 2018 | - | $28.60 K | $28.60 K |
| Dec 2017 | $494.90 K | - | - |
FAQ
- What is Castle Biosciences annual capital expenditures?
- What is the all time high annual CAPEX for Castle Biosciences?
- What is Castle Biosciences annual CAPEX year-on-year change?
- What is Castle Biosciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Castle Biosciences?
- What is Castle Biosciences quarterly CAPEX year-on-year change?
- What is Castle Biosciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Castle Biosciences?
- What is Castle Biosciences TTM CAPEX year-on-year change?
What is Castle Biosciences annual capital expenditures?
The current annual CAPEX of CSTL is $13.62 M
What is the all time high annual CAPEX for Castle Biosciences?
Castle Biosciences all-time high annual capital expenditures is $13.62 M
What is Castle Biosciences annual CAPEX year-on-year change?
Over the past year, CSTL annual capital expenditures has changed by +$7.99 M (+141.85%)
What is Castle Biosciences quarterly capital expenditures?
The current quarterly CAPEX of CSTL is $6.38 M
What is the all time high quarterly CAPEX for Castle Biosciences?
Castle Biosciences all-time high quarterly capital expenditures is $9.15 M
What is Castle Biosciences quarterly CAPEX year-on-year change?
Over the past year, CSTL quarterly capital expenditures has changed by +$3.92 M (+159.80%)
What is Castle Biosciences TTM capital expenditures?
The current TTM CAPEX of CSTL is $24.55 M
What is the all time high TTM CAPEX for Castle Biosciences?
Castle Biosciences all-time high TTM capital expenditures is $24.55 M
What is Castle Biosciences TTM CAPEX year-on-year change?
Over the past year, CSTL TTM capital expenditures has changed by +$12.94 M (+111.38%)